Factors influencing the length of hospitalisation in intensive care units: A prospective observational study

Pharmacy World and Science

Volumn 26, Issue 5, 2004, Pages 263-267

  Vacca, Franca ^a   Vaiani, Monica ^a   Messori, Andrea ^a   Trippoli, Sabrina ^a   Maltoni, Susanna ^a   Pelagotti, Filippo ^a   Santarlasci, Benedetta ^a   Bardelli, Filippo ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Ospedale Civile di Pistoia   (Italy)

Author keywords

Hospital pharmacy; Intensive care units; Italy; Length of hospitalization; Sepsis; Septic shock

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORTALITY; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; AGED; CONFIDENCE INTERVALS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 4644326926     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000042880.12835.4e     Document Type: Article

References (11)

1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
2. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160: 976-81
3. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998; 157(Pt 1): 1151-8.
4. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601
5. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR et al. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intens Care Med 1998; 24: 663-72.
6. Pitimana-aree S, Forrest D, Brown G, Anis A, Wang XH, Dodek P. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intens Care Med 1998; 24: 217-23.
7. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118: 201-10.
8. Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000; 321: 1103-6.
9. Abraham E, Matthay MA, Dinarello CA, Vincent JT, Cohen J, Opal SM et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000; 28: 232-5.
10. Fagon JY, Chastre J, Vuagnat A, Gibert G. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275: 866-9.
11. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L et al. Stress c in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308-14.